AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding AEON Biopharma, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 25 | 2 | 30 | +7 |
| Shares | 9.42M | 3.95M | 9.57M | +4.10M (+74.8%) |
| Value | $8.73M | $3.57M | $10.1M | +$4.89M (+94.6%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held AEON Biopharma, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 3,341,204 | $3.51M | 0.68% |
| BlackRock, Inc. | 265,150 | $278.4K | 0.00% |
| Two Sigma Investments, LP | 65,208 | $68.5K | 0.00% |
| CAPROCK Group, Inc. | 62,686 | $65.8K | 0.00% |
| UBS Group AG | 57,635 | $60.5K | 0.00% |
| LPL Financial LLC | 26,840 | $28.2K | 0.00% |
| HighTower Advisors, LLC | 23,776 | $25.0K | 0.00% |
| Cutter & CO Brokerage, Inc. | 14,027 | $14.7K | 0.00% |
| Lido Advisors, LLC | 12,894 | $13.5K | 0.00% |
| CI Private Wealth, LLC | 12,681 | $13.3K | 0.00% |
| Cetera Investment Advisers | 11,930 | $12.5K | 0.00% |
| BBR Partners, LLC | 11,586 | $12.2K | 0.00% |
| Steward Partners Investment Advisory, LLC | 7,200 | $7.56K | 0.00% |
| CIBC Private Wealth Group, LLC | 2,417 | $2.54K | 0.00% |
Sold out (7)
Institutions that held AEON Biopharma, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Davidson Kempner Capital Management LP | 90,053 | $94.6K |
| Millennium Management LLC | 50,985 | $53.5K |
| Y-Intercept (Hong Kong) Ltd | 20,942 | $22.0K |
| Kim, LLC | 15,560 | $16.3K |
| CSS LLC | 12,135 | $12.7K |
| Goldman Sachs Group Inc | 11,333 | $11.9K |
| Qube Research & Technologies Ltd | 1,056 | $1.11K |
Not filed for Q3 2024 yet (2)
Institutions that held AEON Biopharma, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Atalaya Capital Management LP | 3,675,000 | $3.28M |
| BlackRock Inc. | 272,317 | $285.9K |